Literature DB >> 1280389

Phenotypic analysis of bronchoalveolar lavage lymphocytes from acquired immunodeficiency patients with and without Pneumocystis carinii pneumonia.

J Guzman1, Y M Wang, H Teschler, K Kienast, N Brockmeyer, U Costabel.   

Abstract

A study was performed to reveal possible differences in lymphocyte subpopulations from bronchoalveolar lavage (BAL) of acquired immunodeficiency patients with and without Pneumocystis carinii pneumonia. Forty-one consecutive human immunodeficiency virus-seropositive patients were studied. Pneumocystis carinii infection was detected in the BAL fluid from 18 patients. The BAL lymphocyte subpopulations were determined by surface marker analysis with the immunoperoxidase slide assay. No significant differences in the percentage of CD4+ and CD8+ lymphocytes were found between the two groups. The percentage of CD57+ natural killer (NK) cells was significantly higher in the Pneumocystis carinii-negative group than in the -positive group. Since NK cells protect from microbial infections, it is conceivable that the loss of CD57+ NK cells may be one of the phenomena leading to the immunodeficiency state that underlies the pulmonary complications characteristic of the acquired immunodeficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280389

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  3 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes.

Authors:  M S Bartlett; W L Current; A Orazi; N L Bauer; R S Neiman; S F Queener; J W Smith
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

Review 3.  Pneumocystis Pneumonia: Immunity, Vaccines, and Treatments.

Authors:  Aaron D Gingerich; Karen A Norris; Jarrod J Mousa
Journal:  Pathogens       Date:  2021-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.